Detalhe da pesquisa
1.
An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
Reprod Biol Endocrinol
; 15(1): 17, 2017 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270212
2.
Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis.
Reprod Biomed Online
; 33(1): 56-60, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27178762
3.
Impact of patient characteristics on the pharmacokinetics of corifollitropin alfa during controlled ovarian stimulation.
Br J Clin Pharmacol
; 82(1): 74-82, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26991902
4.
Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial.
Eur J Contracept Reprod Health Care
; 21(4): 303-9, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339759
5.
Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia.
Blood
; 129(13): 1876-1878, 2017 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126927
6.
Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients.
Anesthesiology
; 121(5): 969-77, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25208233
7.
Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
Pediatr Nephrol
; 28(5): 737-43, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23207876
8.
An Innovative Health Literacy Approach Designed to Improve Patient Understanding of Medication Labeling.
Ther Innov Regul Sci
; 55(6): 1180-1192, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341945
9.
Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects.
Platelets
; 21(3): 191-8, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20163197
10.
Flushing profile of extended-release niacin/laropiprant at initiation of therapy in Asian lipid clinic patients.
Cardiology
; 114(3): 192-8, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19602880
11.
Comparison of the follicular output rate after controlled ovarian stimulation with daily recombinant follicle-stimulating hormone versus corifollitropin alfa.
Eur J Obstet Gynecol Reprod Biol
; 232: 101-105, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529793
12.
Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial.
Fertil Steril
; 106(2): 300-305.e5, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27090863
13.
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
J Clin Lipidol
; 9(1): 65-71, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25670362
14.
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.
Vasc Health Risk Manag
; 10: 279-90, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24855368
15.
A randomized, open-label, dose-response study of losartan in hypertensive children.
Clin J Am Soc Nephrol
; 9(8): 1441-8, 2014 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24875194
16.
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia.
Atherosclerosis
; 230(1): 52-60, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23958252
17.
Effectiveness and safety of laropiprant on niacin-induced flushing.
Am J Cardiol
; 110(6): 817-22, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22683042
18.
Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndrome.
J Clin Lipidol
; 4(6): 515-21, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21122699
19.
Lipid-modifying efficacy of extended release niacin/laropiprant in Asian patients with primary hypercholesterolemia or mixed hyperlipidemia.
J Clin Lipidol
; 3(3): 179-86, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-21291812